KJ Muldoon, a 10-month-old baby, was diagnosed with the genetic disease carbamoyl-phosphate synthetase 1 deficiency after he ...

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

Beam Therapeutics rises after the FDA grants orphan drug status to its gene-editing therapy BEAM-101 for sickle cell disease.

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to ...

Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised ...

Geron is an undervalued company with a potential for significant revenue growth, especially via its first-in-class drug ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Beta-lactam allergy was ruled out in more than 85% of patients, and 35.8% went on to be treated with beta-lactam with no hypersensitivity reactions, new research shows.

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

Early access via large-scale clinical study to establish the validity and utility of the FirstGene TM screen ...